MANILA, Philippines — The Food and Drug Administration (FDA) did not succumb to pressure when it decided to grant compassionate special permit (CSP) to two hospitals for the human use of ivermectin to fight COVID-19, Director-General Eric Domingo said Friday.
Interviewed in INQUIRER.net’s INQside Look, Domingo denied that the FDA’s decision to grant a CSP was due to pressure, saying they only followed their protocol and regulations.
“Our rules and regulations have been there since last year for the CSPs for anti-COVID-19 medicine. Dito kasi, may checklist ka naman. Kapag nag-apply, isa-submit mo. Pag pumasa, bibigyan ka ng permit,” Domingo said.
“Hindi naman pressure yun. …
Keep on reading: FDA chief denies pressure in allowing compassionate use of ivermectin